J-STAGE Home  >  Publications - Top  > Bibliographic Information

Circulation Journal
Vol. 77 (2013) No. 7 1791-1798



Metabolic Disorder

Background: The aim of this study was to compare the effect on endothelial function of increasing statin dose to add-on ezetimibe in patients with coronary artery disease (CAD) already treated with statin. Methods and Results: Two-hundred and forty-three patients with CAD and low-density lipoprotein cholesterol (LDL-C) ≥70mg/dl even after treatment with atorvastatin (10mg) were prospectively randomized to the ezetimibe addition (10mg) group (A10E10; n=117) or to the double atorvastatin dose (to 20mg; A20; n=133) group for 12 weeks. Primary endpoint was change in endothelial function measured by logarithmic-scale reactive hyperemia index (L_RHI). After treatment, high-sensitivity C-reactive protein (hs-CRP) and all lipids except triglyceride and high-density lipoprotein cholesterol were significantly reduced in both groups. The mean percent changes in LDL-C for the A10E10 and A20 groups were –25.8% and –9.1%, respectively (P<0.001). L_RHI increased from 0.47 to 0.62 in the A20 group (P<0.001), but not in the A10E10 group (from 0.45 to 0.48, P=0.399). Absolute change in L_RHI was significantly higher in the A20 than A10E10 group (0.02±0.29 vs. 0.16±0.27, P<0.001). Conclusions: Statin and ezetimibe have different effects on endothelial function independent from LDL-C-lowering effects.  (Circ J 2013; 77: 1791–1798)


Article Tools

Share this Article